- Home
- NCPL vs MTNB Comparison
NCPL vs MTNB Comparison
Compare NCPL & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCPL
- MTNB
- Stock Information
- Founded
- NCPL 1984
- MTNB 2013
- Country
- NCPL United States
- MTNB United States
- Employees
- NCPL N/A
- MTNB N/A
- Industry
- NCPL Investment Managers
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- NCPL Finance
- MTNB Health Care
- Exchange
- NCPL Nasdaq
- MTNB Nasdaq
- Market Cap
- NCPL 4.3M
- MTNB 3.6M
- IPO Year
- NCPL N/A
- MTNB N/A
- Fundamental
- Price
- NCPL $4.08
- MTNB $0.91
- Analyst Decision
- NCPL
- MTNB Hold
- Analyst Count
- NCPL 0
- MTNB 1
- Target Price
- NCPL N/A
- MTNB N/A
- AVG Volume (30 Days)
- NCPL 568.1K
- MTNB 552.6K
- Earning Date
- NCPL 07-28-2025
- MTNB 08-13-2025
- Dividend Yield
- NCPL N/A
- MTNB N/A
- EPS Growth
- NCPL N/A
- MTNB N/A
- EPS
- NCPL N/A
- MTNB N/A
- Revenue
- NCPL $812,612.00
- MTNB N/A
- Revenue This Year
- NCPL N/A
- MTNB N/A
- Revenue Next Year
- NCPL $101.16
- MTNB N/A
- P/E Ratio
- NCPL N/A
- MTNB N/A
- Revenue Growth
- NCPL N/A
- MTNB N/A
- 52 Week Low
- NCPL $1.41
- MTNB $0.47
- 52 Week High
- NCPL $11.90
- MTNB $9.60
- Technical
- Relative Strength Index (RSI)
- NCPL 68.27
- MTNB 55.61
- Support Level
- NCPL $3.82
- MTNB $0.83
- Resistance Level
- NCPL $5.75
- MTNB $0.95
- Average True Range (ATR)
- NCPL 0.63
- MTNB 0.11
- MACD
- NCPL 0.15
- MTNB -0.01
- Stochastic Oscillator
- NCPL 53.87
- MTNB 28.64
About NCPL Netcapital Inc.
Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.